Back to Search
Start Over
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial
- Source :
- The Lancet; November 2020, Vol. 396 Issue: 10261 p1504-1510, 7p
- Publication Year :
- 2020
-
Abstract
- In the treatment of de-novo coronary small vessel disease, drug-coated balloons (DCBs) are non-inferior to drug-eluting stents (DESs) regarding clinical outcome up to 12 months, but data beyond 1 year is sparse. We aimed to test the long-term efficacy and safety of DCBs regarding clinical endpoints in an all-comer population undergoing percutaneous coronary intervention.
Details
- Language :
- English
- ISSN :
- 01406736 and 1474547X
- Volume :
- 396
- Issue :
- 10261
- Database :
- Supplemental Index
- Journal :
- The Lancet
- Publication Type :
- Periodical
- Accession number :
- ejs54567531
- Full Text :
- https://doi.org/10.1016/S0140-6736(20)32173-5